Press release Biocartis Group NV: BIOCARTIS ANNOUNCES 2021 HALF-YEAR RESULTS ON 2 SEPTEMBER 2021

NEXT STORY
Saniona publicerar sin delårsrapport för det andra kvartalet 2021
PREV STORY
HUTCHMED Initiates a Phase Ib/II Trial of Fruquintinib in Combination with Tislelizumab in Advanced Triple Negative Breast Cancer or Advanced Endometrial Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

SINTX Technologies Announces New Antiviral Test Results

author_avatar
NASDAQ Market News

Celsion GmbH Announces Commencement of Enrollment in Oxford University’s Phase 1 Study with ThermoDox® and Focused Ultrasound in Pancreatic Cancer

author_avatar
NASDAQ Market News

NeuroMetrix Announces That Top-Line Results from a Randomized Controlled Trial of Quell® for Treatment of Fibromyalgia to be Presented at Two Upcoming Pain Medicine Conferences

author_avatar
NASDAQ Market News